| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 15 | +80.00% | -8.13% | +0.77% | -8.90% | -12.21% | — |
| 14d | 15 | +100.00% | -14.61% | +1.74% | -16.35% | -17.87% | — |
| 30d | 15 | +100.00% | -12.84% | +3.28% | -16.12% | -15.22% | — |
| 60d | 15 | +86.67% | -21.65% | +0.85% | -22.49% | -24.22% | — |
| 90d | 15 | +86.67% | -22.22% | +5.00% | -27.23% | -34.31% | — |
| 180d | 15 | +86.67% | -11.83% | +10.46% | -22.28% | -24.53% | — |
| 1y | 15(2 pending) | +100.00% | -25.66% | +22.13% | -47.78% | -49.06% | — |
| 2y | 15(2 pending) | +100.00% | -69.89% | +38.90% | -108.78% | -107.06% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 50,000 | $19.43 | $971.5K | 2,824,551 | Jun 17, 2026 | Jun 17, 2026 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 50,000 | $18.70 | $935.0K | 2,874,551 | Jun 16, 2026 | Jun 17, 2026 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 50,000 | $18.89 | $944.5K | 2,924,551 | Jun 15, 2026 | Jun 17, 2026 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASEGRANT Stock grant | 520,342 | — | — | 520,342 | Jan 7, 2026 | Jan 9, 2026 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE Chief Scientific Officer | 35,389 | — | — | 35,389 | Dec 19, 2025 | Dec 22, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 35,389 | — | — | 0 | Dec 19, 2025 | Dec 22, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 1,052 | — | — | 0 | Dec 19, 2025 | Dec 22, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 72,908 | $14.43 | $1.05M | 0 | Dec 9, 2025 | Dec 10, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 130,000 | $15.08 | $1.96M | 72,908 | Dec 8, 2025 | Dec 10, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 48,978 | — | — | 35,389 | Sep 2, 2025 | Sep 4, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE Chief Scientific Officer | 48,978 | — | — | 202,908 | Sep 2, 2025 | Sep 4, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASEGRANT Stock grant | 139,273 | — | — | 139,273 | Feb 27, 2025 | Mar 3, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE Chief Scientific Officer | 111,949 | — | — | 153,930 | Jan 20, 2025 | Jan 22, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 3,328 | — | — | 2,508 | Jan 20, 2025 | Jan 22, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 111,949 | — | — | 84,367 | Jan 20, 2025 | Jan 22, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 1,456 | — | — | 1,052 | Jan 20, 2025 | Sep 4, 2025 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 31,910 | $55.00 | $1.76M | 2,925,573 | Feb 28, 2024 | Feb 29, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 28,090 | $55.00 | $1.54M | 41,981 | Feb 28, 2024 | Feb 29, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 29,431 | $55.00 | $1.62M | 70,071 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 29,491 | $55.00 | $1.62M | 2,957,483 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 569 | $55.30 | $31.5K | 99,502 | Feb 21, 2024 | Feb 22, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 509 | $55.31 | $28.2K | 2,986,974 | Feb 21, 2024 | Feb 22, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 10,000 | $57.43 | $574.3K | 100,071 | Feb 20, 2024 | Feb 22, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 10,000 | $57.45 | $574.5K | 2,987,483 | Feb 20, 2024 | Feb 22, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 10,000 | $60.15 | $601.5K | 110,071 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 10,000 | $60.15 | $601.5K | 2,997,483 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 10,000 | $60.17 | $601.7K | 3,007,483 | Feb 15, 2024 | Feb 16, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 10,000 | $60.16 | $601.6K | 120,071 | Feb 15, 2024 | Feb 16, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 10,000 | $62.42 | $624.2K | 3,017,483 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE10b5-1 10b5-1 plan | 10,000 | $62.43 | $624.3K | 130,071 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE Chief Scientific Officer | 41,981 | — | — | 140,071 | Oct 1, 2023 | Oct 3, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 2,527,477 | — | — | 0 | Oct 1, 2023 | Oct 3, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 41,981 | — | — | 196,316 | Oct 1, 2023 | Oct 3, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 1,248 | — | — | 5,836 | Oct 1, 2023 | Oct 3, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 75,136 | — | — | 0 | Oct 1, 2023 | Oct 3, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE Chief Scientific Officer | 2,527,477 | — | — | 3,027,483 | Oct 1, 2023 | Oct 3, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE Chief Scientific Officer | 98,090 | — | — | 98,090 | Apr 5, 2023 | Apr 7, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 98,090 | — | — | 238,297 | Apr 5, 2023 | Apr 7, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 500,006 | — | — | 2,527,477 | Apr 5, 2023 | Apr 7, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | PURCHASE Chief Scientific Officer | 500,006 | — | — | 500,006 | Apr 5, 2023 | Apr 7, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 14,864 | — | — | 75,136 | Apr 5, 2023 | Apr 7, 2023 ↗ | View → |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | SALE Chief Scientific Officer | 2,916 | — | — | 7,084 | Apr 5, 2023 | Apr 7, 2023 ↗ | View → |